BioGaia publishes annual report for 2017

Today, BioGaia AB (publ) publishes the Annual Report for the financial year 2017. The report is held available at BioGaia’s website www.biogaia.com under the section "Investors – Financial reports ". Shareholders and other stakeholders wishing to have the annual report sent to them may request so by e-mail to info@biogaia.se.

This is information that BioGaia AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 10:00 CET on 26 March 2018.

Latest press releases from BioGaia
2018-03-26 Notice to attend the Annual General Meeting of BioGaia AB (publ)
2018-03-23 Dr Reddy’s launches BioGaia Protectis drops in India
2018-03-19 BioGaia’s oral health probiotic launched in several European markets as GUM PerioBalance

For additional information please contact
Axel Sjöblad, Managing Director, BioGaia: +46 8 555 293 00

BioGaia is an innovative Swedish healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are sold through local distribution partners in around 90 countries worldwide. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. www.biogaia.com

Tags:

About Us

BioGaia is a healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri, which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com If you need more information about BioGaia and our products please visit our website or download our press kit from: http://www.biogaia.com/press-material